Literature DB >> 24697205

RNase-L control of cellular mRNAs: roles in biologic functions and mechanisms of substrate targeting.

Sarah E Brennan-Laun1, Heather J Ezelle, Xiao-Ling Li, Bret A Hassel.   

Abstract

RNase-L is a mediator of type 1 interferon-induced antiviral activity that has diverse and critical cellular roles, including the regulation of cell proliferation, differentiation, senescence and apoptosis, tumorigenesis, and the control of the innate immune response. Although RNase-L was originally shown to mediate the endonucleolytic cleavage of both viral and ribosomal RNAs in response to infection, more recent evidence indicates that RNase-L also functions in the regulation of cellular mRNAs as an important mechanism by which it exerts its diverse biological functions. Despite this growing body of work, many questions remain regarding the roles of mRNAs as RNase-L substrates. This review will survey known and putative mRNA substrates of RNase-L, propose mechanisms by which it may selectively cleave these transcripts, and postulate future clinical applications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24697205      PMCID: PMC3976596          DOI: 10.1089/jir.2013.0147

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  124 in total

Review 1.  Regulation of mRNA stability in mammalian cells.

Authors:  J Guhaniyogi; G Brewer
Journal:  Gene       Date:  2001-03-07       Impact factor: 3.688

2.  RNase-L-dependent destabilization of interferon-induced mRNAs. A role for the 2-5A system in attenuation of the interferon response.

Authors:  X L Li; J A Blackford; C S Judge; M Liu; W Xiao; D V Kalvakolanu; B A Hassel
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

3.  Monitoring activation of ribonuclease L by 2',5'-oligoadenylates using purified recombinant enzyme and intact malignant glioma cells.

Authors:  L Rusch; B Dong; R H Silverman
Journal:  Methods Enzymol       Date:  2001       Impact factor: 1.600

Review 4.  The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities.

Authors:  Helle Kristiansen; Hans Henrik Gad; Signe Eskildsen-Larsen; Philippe Despres; Rune Hartmann
Journal:  J Interferon Cytokine Res       Date:  2010-12-12       Impact factor: 2.607

5.  A growth factor-inducible nuclear protein with a novel cysteine/histidine repetitive sequence.

Authors:  R N DuBois; M W McLane; K Ryder; L F Lau; D Nathans
Journal:  J Biol Chem       Date:  1990-11-05       Impact factor: 5.157

Review 6.  FIH-dependent asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.

Authors:  Matthew E Cockman; James D Webb; Peter J Ratcliffe
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 7.  Tristetraprolin: roles in cancer and senescence.

Authors:  Christina R Ross; Sarah E Brennan-Laun; Gerald M Wilson
Journal:  Ageing Res Rev       Date:  2012-02-24       Impact factor: 10.895

8.  RNase-L deficiency exacerbates experimental colitis and colitis-associated cancer.

Authors:  Tiha M Long; Arindam Chakrabarti; Heather J Ezelle; Sarah E Brennan-Laun; Jean-Pierre Raufman; Irina Polyakova; Robert H Silverman; Bret A Hassel
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

9.  The p38/MK2-driven exchange between tristetraprolin and HuR regulates AU-rich element-dependent translation.

Authors:  Christopher Tiedje; Natalia Ronkina; Mohammad Tehrani; Sonam Dhamija; Kathrin Laass; Helmut Holtmann; Alexey Kotlyarov; Matthias Gaestel
Journal:  PLoS Genet       Date:  2012-09-27       Impact factor: 5.917

10.  Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2',5'-oligoadenylate synthetase from prostate cancer cells.

Authors:  Ross J Molinaro; Babal Kant Jha; Krishnamurthy Malathi; Sooryanarayana Varambally; Arul M Chinnaiyan; Robert H Silverman
Journal:  Nucleic Acids Res       Date:  2006-12-01       Impact factor: 16.971

View more
  29 in total

1.  RNase L Antiviral Activity Is Not a Critical Component of the Oas1b-Mediated Flavivirus Resistance Phenotype.

Authors:  J C Madden; Dan Cui; M A Brinton
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

2.  Post-transcriptional control of cytokine gene expression in health and disease.

Authors:  Khalid S A Khabar
Journal:  J Interferon Cytokine Res       Date:  2014-02-19       Impact factor: 2.607

3.  Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function.

Authors:  Tiha M Long; Shahista Nisa; Michael S Donnenberg; Bret A Hassel
Journal:  Infect Immun       Date:  2014-04-14       Impact factor: 3.441

4.  ABCE1 is essential for S phase progression in human cells.

Authors:  Marina Toompuu; Kairi Kärblane; Pille Pata; Erkki Truve; Cecilia Sarmiento
Journal:  Cell Cycle       Date:  2016-03-17       Impact factor: 4.534

5.  Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families.

Authors:  Danielle M Karyadi; Shanshan Zhao; Qianchuan He; Laura McIntosh; Jonathan L Wright; Elaine A Ostrander; Ziding Feng; Janet L Stanford
Journal:  Int J Cancer       Date:  2014-10-13       Impact factor: 7.396

6.  A human cellular noncoding RNA activates the antiviral protein 2'-5'-oligoadenylate synthetase 1.

Authors:  Brenda M Calderon; Graeme L Conn
Journal:  J Biol Chem       Date:  2018-08-20       Impact factor: 5.157

7.  RNase L Reprograms Translation by Widespread mRNA Turnover Escaped by Antiviral mRNAs.

Authors:  James M Burke; Stephanie L Moon; Tyler Matheny; Roy Parker
Journal:  Mol Cell       Date:  2019-09-04       Impact factor: 17.970

8.  Human RNase L tunes gene expression by selectively destabilizing the microRNA-regulated transcriptome.

Authors:  Sneha Rath; Jesse Donovan; Gena Whitney; Alisha Chitrakar; Wei Wang; Alexei Korennykh
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-14       Impact factor: 11.205

9.  RNase L attenuates mitogen-stimulated gene expression via transcriptional and post-transcriptional mechanisms to limit the proliferative response.

Authors:  Sarah E Brennan-Laun; Xiao-Ling Li; Heather J Ezelle; Thiagarajan Venkataraman; Perry J Blackshear; Gerald M Wilson; Bret A Hassel
Journal:  J Biol Chem       Date:  2014-10-09       Impact factor: 5.157

10.  RNase L interacts with Filamin A to regulate actin dynamics and barrier function for viral entry.

Authors:  Krishnamurthy Malathi; Mohammad Adnan Siddiqui; Shubham Dayal; Merna Naji; Heather J Ezelle; Chun Zeng; Aimin Zhou; Bret A Hassel
Journal:  mBio       Date:  2014-10-28       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.